TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29389692

Group type: EXPERIMENTAL
Intervention: OPT drop-box height group (n = 24)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: FIXED drop-box height group (n = 25)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 73
Study: 26481764

Group type: EXPERIMENTAL
Intervention: Kidney injury molecule‐1 (KIM‐1) measured 24 h after operation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: N‐acetyl‐glucosaminidase (NAG) measured preop and postop 24 h
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Neutrophil gelatinase‐associated lipocalin (NGAL) measured 24 h after operation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Liver‐type fatty acid binding protein (LFABP) measured preop and postop 24 h
Number of subjects: 29
Study: 24682986

Group type: COMPARATOR
Intervention: Epidural analgesia with 0.1% ropivacaine+0.1 μg/mL sufentanil (for postoperative 48 h)+injected pethidine on demand
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral analgesia with controlled-release oxycodone (2x15 mg for the first postoperative 24 h; 2x10 mg for the second postoperative 24 h)+paracetamol and tramadol hydrochloride tablets (8x1 tablet for the postoperative 48 h) orally+injected pethidine on demand
Number of subjects: 60
Study: 22819741

Group type: EXPERIMENTAL
Intervention: Negative graduated compression bandage (NGCB) with median calf pressure of 62 mmHg and distal leg pressure of 50 mmHg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Graduated compression bandage (GCB) with median calf pressure of 28 mmHg and distal leg pressure of 54 mmHg
Number of subjects: 20
Study: 20455671

Group type: EXPERIMENTAL
Intervention: Qualified healthcare professionals
Number of subjects: 460

Group type: COMPARATOR
Intervention: Trainee healthcare professionals
Number of subjects: 460
Study: 18541641

Group type: EXPERIMENTAL
Intervention: 3-day communication skills course
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 172
Study: 16398945

Group type: EXPERIMENTAL
Intervention: Treadmill training with stimulation (TS)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Overground training with stimulation (OG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Treadmill training with manual assistance (TM)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Treadmill training with robotic assistance (LR)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 27
Study: 12097688

Group type: EXPERIMENTAL
Intervention: Zinc-restricted diet (4.6 mg/d) during the 10-week zinc-restriction (ZR) period
Number of subjects: 8

Group type: COMPARATOR
Intervention: Zinc supplements (9.1 mg/d) during the 5-week baseline (BL) and 5-week repletion (RP) periods
Number of subjects: 8
Study: 10424318

Group type: EXPERIMENTAL
Intervention: digoxin 0.25 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 7548447

Group type: EXPERIMENTAL
Intervention: Se-rich bread with 100, 200, and 300 micrograms Se daily for 6 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: 400 micrograms selenomethionine daily for 15 weeks
Number of subjects: 42
Study: 2125742

Group type: EXPERIMENTAL
Intervention: 35 micrograms enprostil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 70 micrograms enprostil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6998594

Group type: EXPERIMENTAL
Intervention: 3 doses of the live oral typhoid vaccine Ty21a (1 x 10(9)‐8 x 10(9) live bacteria)
Number of subjects: 32388

Group type: COMPARATOR
Intervention: 3 doses of placebo
Number of subjects: 32388
Study: 31489717

Group type: EXPERIMENTAL
Intervention: Diabetes health program (n=75)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Publicly available diabetes health brochure (n=71)
Number of subjects: 146
Study: 31182448

Group type: EXPERIMENTAL
Intervention: riluzole
Number of subjects: 210

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 210
Study: 29143869

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg with Ketanserin 40 mg
Number of subjects: 20
Study: 26595710

Group type: EXPERIMENTAL
Intervention: Surgical stabilization of rib fractures (SSRF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Optimal medical management
Number of subjects: 70
Study: 24428733

Group type: EXPERIMENTAL
Intervention: SNPs in CHRNA4
Number of subjects: 702

Group type: COMPARATOR
Intervention: SNPs in other CHRNs (CHRNB2, CHRNA2, CHRNB3A6, CHRNA5A3B4)
Number of subjects: 702
Study: 22498022

Group type: EXPERIMENTAL
Intervention: Faith-placed lay health advisor (LHA) intervention with home visits and newsletters
Number of subjects: 345

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 345
Study: 20639792

Group type: EXPERIMENTAL
Intervention: Preterm formula containing 0.8 g/100 mL short‐chain galacto‐oligosaccharides/long‐chain fructo‐oligosaccharides in a 9:1 ratio
Number of subjects: 160

Group type: COMPARATOR
Intervention: Identical formula without prebiotic oligosaccharides
Number of subjects: 160
Study: 17636280

Group type: EXPERIMENTAL
Intervention: ZK230211 (1, 4, or 8 microg/24 h)
Number of subjects: 42

Group type: COMPARATOR
Intervention: LNG (20 microg/24 h)
Number of subjects: 42
Study: 15785272

Group type: EXPERIMENTAL
Intervention: Abdominal quilting sutures
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard abdominal closure
Number of subjects: 71
Study: 11887119

Group type: EXPERIMENTAL
Intervention: Mailed physician reminders (4 monthly reminders)
Number of subjects: 8325
Study: 9388378

Group type: EXPERIMENTAL
Intervention: Gentian violet plus dibutyryl cAMP (GVcAMP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Povidone-iodine plus sugar (IS)
Number of subjects: 19
Study: 7940487

Group type: EXPERIMENTAL
Intervention: Hemofiltration during CPB
Number of subjects: 11

Group type: COMPARATOR
Intervention: No hemofiltration during CPB
Number of subjects: 11
Study: 3359804

Group type: EXPERIMENTAL
Intervention: Single oral dose of 110 mg retinyl palmitate (vitamin A supplementation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-supplemented group (control)
Number of subjects: 0
Study: 29808613

Group type: EXPERIMENTAL
Intervention: Lifestyle orientation programme (IG)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Routine guidelines of health services (CG)
Number of subjects: 71
Study: 26652051

Group type: EXPERIMENTAL
Intervention: Progesterone treatment
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Extended model
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Lab model
Number of subjects: 1124

Group type: COMPARATOR
Intervention: IMPACT models
Number of subjects: 1124
Study: 25377415

Group type: EXPERIMENTAL
Intervention: Telementored education through Google Glass (Group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bedside education from the same expert (Group B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 18
Study: 23116343

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MiniArc
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ajust
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 43
Study: 20160423

Group type: EXPERIMENTAL
Intervention: Tooth brushing with toothpaste (N=9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-tooth brushing (Control group, N=8)
Number of subjects: 17
Study: 18418239

Group type: EXPERIMENTAL
Intervention: Adjunctive balloon postdilation (ABP)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No adjunctive balloon postdilation (no ABP)
Number of subjects: 88
Study: 16003035

Group type: COMPARATOR
Intervention: Mosaicplasty
Number of subjects: 47

Group type: COMPARATOR
Intervention: Autologous chondrocyte implantation (ACI)
Number of subjects: 47
Study: 14657616

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no tamoxifen)
Number of subjects: 50
Study: 11186472

Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 32
Study: 9100143

Group type: EXPERIMENTAL
Intervention: Fourth-year medical student preceptors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Faculty preceptors
Number of subjects: 100
Study: 8161886

Group type: EXPERIMENTAL
Intervention: TP5
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 3514363

Group type: EXPERIMENTAL
Intervention: metronidazole (200 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: PVP-iodine
Number of subjects: 37

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 37
Study: 3401284

Group type: EXPERIMENTAL
Intervention: Bezafibrate (BZF) 400-600 mg/day for 15-30 days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bezafibrate (BZF) 400 mg/day for 15 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 30838669

Group type: COMPARATOR
Intervention: Concurrent training based on physical activity recommendation from WHO (PAR group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: High-intensity interval training (HIIT group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: High-intensity interval training with whole-body electromyostimulation (WB-EMS group)
Number of subjects: 89
Study: 29165355

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (HI-NI; 140 mL containing 12.9 mmol nitrate)
Number of subjects: 12
Study: 25862491

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) program, 12 group sessions, twice a week, 30 min each.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 24304733

Group type: EXPERIMENTAL
Intervention: Oral methionine load (OML) test
Number of subjects: 353
Study: 19734597

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 349

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 349
Study: 16983180

Group type: EXPERIMENTAL
Intervention: Methimazole treatment for 2 years
Number of subjects: 232
Study: 15504380

Group type: EXPERIMENTAL
Intervention: 200 mg oral mifepristone followed by 400 microg oral misoprostol 2 days later
Number of subjects: 208
Study: 11419426

Group type: EXPERIMENTAL
Intervention: abciximab plus stenting
Number of subjects: 300

Group type: COMPARATOR
Intervention: placebo plus stenting
Number of subjects: 300
Study: 9642335

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 128

Group type: COMPARATOR
Intervention: Vitamin C (placebo)
Number of subjects: 128
Study: 8273924

Group type: EXPERIMENTAL
Intervention: Laryngeal mask
Number of subjects: 20

Group type: COMPARATOR
Intervention: Orotracheal tube
Number of subjects: 20
Study: 3814034

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 29030001

Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Transanal Endoscopic Microsurgery (TEM)
Number of subjects: 203

Group type: COMPARATOR
Intervention: EMR of adenomas
Number of subjects: 203
Study: 27288475

Group type: EXPERIMENTAL
Intervention: Vilaprisan (VPR) 0.1 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Vilaprisan (VPR) 0.5 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Vilaprisan (VPR) 1 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Vilaprisan (VPR) 2 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Vilaprisan (VPR) 5 mg
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 24810871

Group type: EXPERIMENTAL
Intervention: Metacognitive therapy (MCT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 48
Study: 23546172

Group type: EXPERIMENTAL
Intervention: Pemetrexed 600 mg/m², D1 i.v. q21; Carboplatin, AUC 5, D1 i.v. q21 (Arm A)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,200 mg/m² D1, D8 i.v. q21; Vinorelbine 30 mg/m² D1, D8 i.v. q21 (Arm B)
Number of subjects: 135
Study: 21219813

Group type: EXPERIMENTAL
Intervention: Intravenous heparin at 2 IU/ml
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no heparin)
Number of subjects: 76
Study: 18596551

Group type: EXPERIMENTAL
Intervention: Perfectionism program
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Media literacy program
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control classes
Number of subjects: 127
Study: 16860852

Group type: EXPERIMENTAL
Intervention: 6 cycles of carboplatin (7.5 AUC over 30 min) and paclitaxel (175 mg/m2 over 3 h) every 21 days
Number of subjects: 457

Group type: COMPARATOR
Intervention: 3 cycles of carboplatin (7.5 AUC over 30 min) and paclitaxel (175 mg/m2 over 3 h) every 21 days
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: 6 cycles of carboplatin and paclitaxel
Number of subjects: 457

Group type: COMPARATOR
Intervention: 3 cycles of carboplatin and paclitaxel
Number of subjects: 457
Study: 12930333

Group type: EXPERIMENTAL
Intervention: Purpura-free treatment with pulsed-dye laser
Number of subjects: 15

Group type: COMPARATOR
Intervention: Purpura treatment with pulsed-dye laser
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Purpura-free treatment with pulsed-dye laser (fewer than 250 pulses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Purpura-free treatment with pulsed-dye laser (greater than 250 pulses)
Number of subjects: 15
Study: 10325893

Group type: EXPERIMENTAL
Intervention: Swimming training (125% of lactate threshold, 6 weeks)
Number of subjects: 16
Study: 8704887

Group type: EXPERIMENTAL
Intervention: Coordinated home visit and office intervention
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Office intervention
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 93
Study: 1722785

Group type: EXPERIMENTAL
Intervention: High dose aprotinin (2,000,000 KIU loading dose, 500,000 KIU/h infusion until skin closure, plus 2,000,000 KIU in priming volume)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (50 patients with similar indication for surgery)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High dose aprotinin in risk patients (redo-operations, infective endocarditis)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group for risk patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High dose aprotinin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lower dosage aprotinin (2,000,000 KIU during induction or in priming volume only)
Number of subjects: 100
Study: 6918343

Group type: EXPERIMENTAL
Intervention: Intravesical prostaglandin E2 (1.5 mg in 50 ml 0.9% NaCl)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NaCl (placebo)
Number of subjects: 20
Study: 31845865

Group type: EXPERIMENTAL
Intervention: Perindopril tert-butylamine tablets
Number of subjects: 20
Study: 29338762

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly plus methotrexate for 36 weeks, followed by randomized treatment with etanercept 50 mg or 25 mg QW plus methotrexate or placebo plus methotrexate for 52 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg or 25 mg QW plus methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus methotrexate
Number of subjects: 0
Study: 26706043

Group type: EXPERIMENTAL
Intervention: l-rhamnose (25.5 g/d)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: inulin (22.4 g/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: control (no supplement)
Number of subjects: 13
Study: 25319696

Group type: EXPERIMENTAL
Intervention: Hippocampal pattern similarity across intervening items during encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classifier trained to discriminate encoding patterns associated with faces versus objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral priming experiment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contextual conditions (single context vs across context boundaries)
Number of subjects: 0
Study: 22676207

Group type: EXPERIMENTAL
Intervention: High left atrial systolic force (LASF) defined as >95th percentile (50 Kdynes/cm(2))
Number of subjects: 1566

Group type: COMPARATOR
Intervention: Normal left atrial systolic force (LASF)
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: High LASF
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: Risk score including absence or presence of aortic valve area and LV mass index
Number of subjects: 1566
Study: 19608589

Group type: EXPERIMENTAL
Intervention: Therapeutic nCPAP
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapeutic nCPAP (at 12 weeks)
Number of subjects: 61
Study: 17509486

Group type: EXPERIMENTAL
Intervention: Rotigotine (up to 16 mg/24 h as a transdermal patch)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Pramipexole (up to 4.5 mg/day orally)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 16202898

Group type: EXPERIMENTAL
Intervention: IV dexmedetomidine (0.5 microg/kg loading dose over 20 minutes, followed by continuous infusion at 0.4 microg/kg/h)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: IV dexmedetomidine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (IV saline at the same calculated loading and infusion rates)
Number of subjects: 28
Study: 12031053

Group type: EXPERIMENTAL
Intervention: Housing improvements including insulation, double-glazing, re-roofing, heating, ventilation, and electrical rewiring.
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Health surveys completed by community nurses, including SF-36 and GHQ 12 questionnaires.
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Questionnaires screening for health problems sent to all residents.
Number of subjects: 580
Study: 9568047

Group type: EXPERIMENTAL
Intervention: IFN‐alpha treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal tissue
Number of subjects: 29
Study: 8534645

Group type: EXPERIMENTAL
Intervention: Warm lignocaine (37 degrees C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold lignocaine (room temperature)
Number of subjects: 60
Study: 2652231

Group type: EXPERIMENTAL
Intervention: 2 mg methysergide
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 80 mg verapamil
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1091123

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (60 patients)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (19 patients)
Number of subjects: 79
Study: 30680627

Group type: EXPERIMENTAL
Intervention: Balneological outpatient treatment (hydrotherapy and peloidotherapy)
Number of subjects: 139
Study: 28317353

Group type: EXPERIMENTAL
Intervention: Tooth‐alveolar bone grafts (Group A, n=24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional tooth transplantation (Group B, n=21)
Number of subjects: 45
Study: 23116597

Group type: EXPERIMENTAL
Intervention: B‐CBT
Number of subjects: 60

Group type: COMPARATOR
Intervention: SHP
Number of subjects: 60
Study: 22188532

Group type: EXPERIMENTAL
Intervention: Ruboxistaurin (RBX), 32 mg daily for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ruboxistaurin (RBX) and Placebo
Number of subjects: 20
Study: 21092474

Group type: EXPERIMENTAL
Intervention: α-lipoic acid 1800 mg daily for 12 weeks
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 19013300

Group type: EXPERIMENTAL
Intervention: Leucine (1 mmol/kg lean body mass)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Leucine plus glucose (25 g)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Leucine alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Glucose (25 g)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Leucine plus glucose
Number of subjects: 13
Study: 16315636

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12873924

Group type: EXPERIMENTAL
Intervention: Small dose lidocaine spinal anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3% 2‐chloroprocaine epidural anesthesia
Number of subjects: 0
Study: 10363872

Group type: EXPERIMENTAL
Intervention: Repeated echocardiographic measurement of left ventricular function
Number of subjects: 0
Study: 1899365

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 micrograms/kg/hr for 24 hours)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nitroglycerin (1 micrograms/kg/min for 24 hours)
Number of subjects: 104
Study: 6309314

Group type: EXPERIMENTAL
Intervention: Misonidazole (Ro 07‐0582, MISO)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 436
Study: 31942969

Group type: EXPERIMENTAL
Intervention: Treadmill training only
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Treadmill training combined with a virtual reality component
Number of subjects: 275
Study: 31051504

Group type: EXPERIMENTAL
Intervention: C12 + Trp (0.4 kcal/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: C12 (0.3 kcal/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Trp (0.1 kcal/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 16
Study: 29364329

Group type: EXPERIMENTAL
Intervention: Comprehensive periodontal treatment (supra and subgingival scaling and root‐planning and periodontal maintenance appointments)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (no comprehensive periodontal treatment)
Number of subjects: 210
Study: 26802147

Group type: EXPERIMENTAL
Intervention: mapatumumab-sorafenib (30 mg/kg on day 1 per 21-day cycle)
Number of subjects: 101

Group type: COMPARATOR
Intervention: placebo-sorafenib (400 mg, twice daily per 21-day cycle)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: mapatumumab-sorafenib
Number of subjects: 101